Should Genetic Testing Be Routine for Breast Cancer?
TOPLINE: Universal testing identified germline pathogenic variants in 7.3% of women with breast cancer, suggesting that traditional risk-based criteria may miss more than a third of BRCA1, BRCA2, or PALB2 carriers. METHODOLOGY: Traditional risk-based …